title: Effect of the combination of ATRA, ATO and DNR on CD11b expression in NB4 cells.
authors.forename: Weihua
authors.initials: W
authors.lastname: Zhang
authors.forename: Fang
authors.initials: F
authors.lastname: Wei
authors.forename: Xiulian
authors.initials: X
authors.lastname: Zhang
authors.forename: Dianqing
authors.initials: D
authors.lastname: Li
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage / Q000494:pharmacology*; D039481:CD11b Antigen / Q000378:metabolism*; D045744:Cell Line, Tumor; D003630:Daunorubicin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism*; D010087:Oxides / Q000008:administration & dosage / Q000494:pharmacology*; D014212:Tretinoin / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D001152:Arsenicals; D039481:CD11b Antigen; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide; D003630:Daunorubicin